The EU Court of Justice renders a preliminary ruling stating that a dispute between an originator and a generics manufacturer constitutes evidence that they are potential competitors (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma)

Drakakakis, Stamatis; Papaefthymiou, Argyris; Gavriilidou, Ellie

Article précédent The EU Court of Justice clarifies the conditions under which pay-for-delay agreements preventing generic versions of a patented medicine from entering the market or delaying such entry may constitute a restriction of competition "by object" or "by effect" as well as an abuse of dominant position (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma) Article suivant The EU Commission imposes fines totally €14M on several companies including a film and TV production company for restricting sales of film merchandise products (NBCUniversal)

30 Jan 2020

The EU Court of Justice renders a preliminary ruling stating that a dispute between an originator and a generics manufacturer constitutes evidence that they are potential competitors (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma)

KEYWORDS

Reference

EU Court of Justice, Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma, Case No. C-307/18, Judgement, 30 January 2020

On 30 January 2020, the Court of Justice of the EU rendered its preliminary ruling in Case C-307/18 – Generics (UK) and Others v CMA (Paroxetine). The case originated in a preliminary reference made by the UK Competition Appeal Tribunal (CAT) relating to an

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

Version PDF

Auteurs

Stamatis Drakakakis
Zepos & Yannopoulos (Athens)

Grèce 34 contributions 3266 visites
Argyris Papaefthymiou
Linklaters (London)

Royaume-Uni 34 contributions 2841 visites
Ellie Gavriilidou
Zepos & Yannopoulos (Athens)

Grèce 29 contributions 2218 visites

Citation

Stamatis Drakakakis, Argyris Papaefthymiou, Ellie Gavriilidou, The EU Court of Justice renders a preliminary ruling stating that a dispute between an originator and a generics manufacturer constitutes evidence that they are potential competitors (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma), 30 janvier 2020, e-Competitions January 2020, Art. N° 100061

Visites 107